Cue Biopharma Inc
CUELatest QuantConomy context for CUE: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Cue Biopharma Inc
QuantConomy has a structured record for CUE. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- CUE
- Name
- Cue Biopharma Inc
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq axs
Recent signals for CUE
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| material agreement | bullish | 95 | Jul 10, 09:35 PM | CUE filed 8-K: Material Definitive Agreement, Unregistered Sales of Equity, Director or Officer Changes - 4 material events - [very strong bullish signal] |
| revenue change | very bearish | 76 | May 14, 12:00 AM | CUE (Q1 2026, revenue): declined 79.3% ($27.47M → $5.69M). [sequential period basis, very bearish signal] |
| eps change | very bearish | 76 | May 14, 12:00 AM | CUE (Q1 2026, diluted eps): EPS declined 285.7% ($-0.28 → $-1.08). [sequential period basis, very bearish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| CUE | NASDAQ | alpaca | Cue Biopharma, Inc. Common Stock |
| CUE | NASDAQ | alphavantage | Cue Biopharma Inc |
| CUE | NASDAQ | fmp | Cue Biopharma, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| — | Ray Sumita | Chief Legal Compliance Officer | — | — | — | — | 3 on EDGAR |
| Jun 1, 2026 | Lin Shao-Lee | Chief Executive Officer | purchase | 90,906 | $11.00 | $999,966 | 4 on EDGAR |
| May 30, 2026 | Meehan Viola Mong | Director | grant | 1,626 | — | — | 4 on EDGAR |
| May 30, 2026 | Camardo Daniel A. | Director | grant | 1,626 | — | — | 4 on EDGAR |
| May 3, 2026 | Lin Shao-Lee | CHIEF EXECUTIVE OFFICER | grant | 327,537 | $0.00 | $0 | 4 on EDGAR |
| Apr 9, 2026 | Warren Lucinda | CHIEF BUSINESS OFFICER | grant | 250,000 | — | — | 4 on EDGAR |
| Apr 9, 2026 | Sandercock Colin | SVP, GENERAL COUNSEL | grant | 200,000 | — | — | 4 on EDGAR |
| Apr 9, 2026 | Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | grant | 100,000 | — | — | 4 on EDGAR |
| Jan 2, 2026 | Broadfoot Jill Marie | Insider | grant | 24,400 | — | — | 4 on EDGAR |
| Jan 2, 2026 | Verheyen Patrick | Insider | grant | 24,400 | — | — | 4 on EDGAR |
| Jan 2, 2026 | Morich Frank | Insider | grant | 24,400 | — | — | 4 on EDGAR |
| Jan 2, 2026 | Garzone Pamela | Insider | grant | 24,400 | — | — | 4 on EDGAR |
| Jan 2, 2026 | Kiener Peter A | Insider | grant | 24,400 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query CUE context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access